Associate Director Medical Affairs

Job Description

Req #: 1902847
Location: Hillingdon, United Kingdom
Job Category: Medical
Work Location: 1 Longwalk Road UB11 1DB
Organization: Scientific Communication
Employee Status: Full-time
Job Type: Regular

Purpose:
The post-holder is an equal partner of the Haematology/Oncology Medical Affairs (MA) Leadership Team along with the Director MA, AD Head of External Research and Medical Liaison, AD Cell Therapy MA Lead.
This leadership team is responsible for:

• The development and implementation of affiliate MA strategy and tactics for product development, commercialization and launch preparation
• Managing, developing and mentoring the Haematology/Oncology MA team
• Providing technical/scientific/medical leadership in the key therapeutic areas/modalities i.e.; cellular therapies, multiple myeloma, lymphoma, myeloid diseases and solid tumours
• Overseeing excellence in external relationships and communications
• Ensuring all activities are of high quality and consistent with UK/Ireland and International compliance requirements
• Working appropriately with Clinical and Commercial teams locally and above country

This strategy-focused team meets on a regular basis to review and monitor progress against the team goals and objectives. Take appropriate action to keep projects and personnel on course, adapt priorities as required and make necessary resource reallocations as and when necessary.
The specific requirement of this role is to manage the Haematology/Oncology Medical Affairs Advisors (MAAs) in the context of the above.
Role and Responsibilities:

• Taking part in regular and ad-hoc Leadership team meetings related to the activities described above as a priority
• Assume joint responsibility for preparing and delivering the Haematology/Oncology strategic medical plans with the other Leadership team members, including regular review and revision of the medical plans to meet the needs of the business
• In collaboration with the Leadership team, regularly review and revise as appropriate the Haematology/Oncology MA workforce deployment to meet the strategic medical plan goals and objectives as they evolve to meet the needs of the business
• Take managerial responsibility for the MAAs; Goal setting, Performance reviews, delivery of tasks against objectives and implementing corrective procedures to address any short-comings
• Responsibility for all Workday and Concur requirements etc related to the MAAs
• Ensure the MAAs are appropriately trained
• Take responsibility for ensuring the MAAs have (Individual Development Plans) IDPs in place and that they are given appropriate opportunities for development
• Maintain oversight of all MAA activities with respect to quality and compliance
• Maintain oversight and contribute to excellent external and internal relationships held by the MAAs
• Partner with commercial colleagues as required in order to meet business needs
• Assume final signatory responsibilities as a backup for the team if and when required

Other responsibilities of the job include:

• Management of contractors, as appropriate
• Workforce planning (with Leadership Team)

Skills and Knowledge Requirements:

• MD, PhD, DPharm or similar
• Strong identification with Celgene values
• Significant expertise in Medical Affairs gained within the Pharmaceutical Industry
• Experience in Haematology and, or Oncology
• Proven line management experience
• Strong Leadership and Management skills
• Excellent communication and organisational skills
• Collaborative style of working
• Final Signatory status

About Us
COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.